Wax Gourd (Benincasa hispida): A Comprehensive Reference
1. Identity and Botanical Classification
Nomenclature
Benincasa hispida (Thunb.) Cogn. — commonly called the wax gourd, ash gourd, white gourd, winter gourd, winter melon, tallow gourd, ash pumpkin, or Chinese preserving melon — is a species of vine. Its scientific name is Benincasa hispida, also known by the synonym B. cerifera, and it belongs to the family Cucurbitaceae.
The plant carries an extensive roster of regional and traditional names. In English-language contexts alone, it is known as wax gourd, tallow gourd, winter melon, white gourd, white pumpkin, ash gourd, fuzzy gourd, ash pumpkin, and hairy melon. In Sanskrit it bears the names Pushpaphala, Kushmanda, Pitaphushpa, and Karkaru. Common names in South Asian usage include Petha, Kohala, and Golkadu, reflecting the plant's deep integration into subcontinental culinary and medicinal traditions. In Traditional Chinese Medicine it is called Dong Gua (冬瓜).
Botanical Description and Natural Source
It is a fast-growing annual vine in the Cucurbitaceae (gourd) family that produces vigorous, sprawling stems that can exceed 3 metres in length, climbing by tendrils and spreading rapidly when given support. The leaves are large, lobed, and coarse-textured with a rough surface. The pale yellow flowers, typical of cucurbits, are pollinated by bees and give rise to heavy, oblong fruits that may weigh anywhere from 5 to over 20 kilograms depending on the cultivar.
Young fruits are covered with fine hairs and are bright green; as they mature, the skin develops a characteristic white, waxy, frost-like coating (white powder bloom), which is the origin of the name "winter melon" (冬瓜). After pollination, they bear obloid fruit 50–60 cm long and 10–25 cm wide.
The wax gourd is native to South and Southeast Asia. It is said to have originated in Japan and Java, but has been widely cultivated in warm climates. One variety of the plant, called chi qua (Benincasa hispida var. chieh-qua), is commonly used in Asian cuisine.
Common Forms and Preparations
The fruits, pericarp, seeds, stems, roots, and leaves of this plant are used in various types of preparations, including as a vegetable, and in pickles, curries, and preserves. Fruits can be consumed either raw or cooked, regardless of their age, and are used as a vegetable and in pickles, stews, preserves, and other recipes.
The fruit can be stored for many months, so when it is harvested during the late summer and autumn months, it can be eaten three to four months later in the wintertime. As a dietary supplement or medicinal preparation, various parts — including fruits, fruit peels, leaves, stems, and roots — are used; seeds and seed oil are also employed in numerous medicinal applications.
2. Traditional and Historical Use
Historical Depth and Geographic Spread
In the Orient, wax gourds, also known as winter melon, have been utilized for thousands of years as food and medicine. Descriptions of the gourd's medicinal value can be found in Chinese texts from the 5th–6th century AD.
Traditional Chinese Medicine (TCM)
Ash gourd has been used in traditional Chinese and Ayurvedic medicine to treat various ailments for centuries. In TCM, the fruit is believed to help flush the body of toxins and to bring balance to an excess of internal heat. Like most green vegetables, winter melon is considered a yin food in traditional Chinese medicine, which means that it has refreshing properties. It is known as an alkaline fruit with a cooling, neutralizing effect within the body, valued for its ability to soothe stomach discomfort and digestive complaints.
In China, the wax gourd is used in soup production by adding it to stir-fries or to pork or beef bones. It is also candied, sliced, and typically consumed at New Year's celebrations. In China, skin softening, the cure of facial blemishes, and the treatment of inflammation and hypertension have also been associated with the plant.
Ayurvedic Tradition
The plant, known in Ayurveda as Kushmanda, is used in the Ayurvedic system of medicine. Ayurvedic medicine uses the fruits to treat a variety of conditions, including coughs, lung disorders, asthma, and epilepsy. Fruits of this plant are traditionally used as a laxative, diuretic, tonic, aphrodisiac, cardiotonic remedy for urinary calculi, blood disease, insanity, epilepsy, and also in cases of jaundice, dyspepsia, fever, and menstrual disorders.
In Ayurveda, winter melon is considered helpful in the treatment of nervous system disorders and epilepsy, and is known to treat peptic ulcers. In India, the fruit is useful in combating dyspepsia, heart diseases, cough, ulcers, gastrointestinal problems, asthma, burning sensation, diabetes mellitus, and urinary diseases.
Other Regional Traditions
In Sri Lanka, the plant is used as an antidote for vegetable poisons and to cure asthma, insanity, hiccough, cholera, and diabetes. In Korea it was used to treat diuresis-related diseases and diabetes.
The juice of the raw ash gourd is used by the Mizo community and indigenous Assamese ethnicities of North-East India as a natural remedy to treat mild to severe dysentery.
The peel of the dried fruit is used for thirst and oliguria occurring due to summer strokes. Gonorrhea is treated with an infusion of the roots in some traditional practices.
The Yogis of India have long regarded ash gourd as one of the most naturally energizing foods due to its high quotient of what Yogic science refers to as "prana," or vital life energy.
Traditional Culinary Preparations
In Indian cuisine, it is traditionally used to prepare a wide variety of dishes. In northern India it is used to prepare a candy called petha. In South Indian cuisine, it is used to make a variety of curries, including sāmbār and a stew called mōr kuḻambu, made with a yogurt base.
3. Key Constituents and Active Compounds
General Phytochemical Overview
Volatile oils, flavonoids, saccharides, glycosides, vitamins, proteins, β-sitosterin, minerals, carotenes, and uronic acid are among the major constituents of B. hispida fruits, according to phytochemical analysis. Scientific reports suggest that B. hispida possesses many important nutritious substances, including vitamins, natural sugars, amino acids, organic acids, and mineral elements.
Triterpenes and Sterols
Among the most pharmacologically studied phytochemicals, phytochemical review indicates the presence of triterpenes — alnusenol, multiflorenol, iso-multiflorenol — the flavone iso-vitexin, and the sterols lupeol, lupeol acetate, and beta-sitosterol.
Phytochemical investigations also suggest the presence of monoterpene hydrocarbons (α-pinene, p-cymene, and limonene), triterpenoids (including oleanolic acid glycoside derivatives), and a wide range of flavonoids including astilbin, catechin, dihydroxyflavan, hydroxyflavan, iso-vitexin, myricetin, naringenin, and quercetin, as well as the flavonoid O-glycoside rutin, and sterols including stigmasterol, α-spinasterol, and daucosterol.
Flavonoids and Phenolics
LC-HRMS analysis has identified 28 phytochemicals in the hydroalcoholic extract of Benincasa hispida, predominantly belonging to the categories of flavonoids, phenolics, triterpenoids, cucurbitacins, sterol glycosides, and coumarins. The presence of catechin, naringenin, kaempferol, cucurbitacin E, cucurbitacin I, dihydrocucurbitacin B, quercetin, myricetin, and 3-hydroxyflavone demonstrates Benincasa hispida as a valuable source of bioactive molecules.
Several other bioactive compounds present include isomultiflorenyl acetate, isovitexin, 1-sinapoylglucose, multiflorenol, 5-gluten-3-β-ylacetate, alnusenol, and benzylalcohol-O-α-l-arabinopyranosyl-(1-6)-β-d-glucopyranoside.
Seed Composition
The seeds contain a significant proportion of fatty acids (24.3%), of which the majority are unsaturated, with the principal components of the seed extract being oleic and linoleic acids. The extracted seed oil is mainly constituted of linoleic acid, accounting for approximately 67.37% of the total fatty acids. The composition of the fruits is predominantly characterized by triterpenoids, flavonoids, glycosides, saccharides, carotenes, vitamins, β-sitosterol, uronic acid, n-triacontanol, tannins, and an array of amino acids.
Key Mechanistic Roles of Identified Compounds
- Triterpenes (alnusenol, multiflorenol): Fruit methanol extract inhibited histamine release. Two triterpenes — multiflorenol and alnusenol — exerted notable inhibitory effects in this context.
- Flavonoids (iso-vitexin, quercetin, naringenin): Activity evaluation of isolated compounds showed that eight compounds exhibited significant activity against advanced glycation end-products and α-glucosidase. Among these, flavonoid compounds showed strong activity.
- Tannins: The tannins found in the plant demonstrate notable inhibitory effects on the activity of pancreatic lipase and the absorption of fats from the intestine.
- Gastroprotective mechanism: The mechanism of gastroprotective activity may be attributed to reduction in vascular permeability, free radical generation, and lipid peroxidation, along with strengthening of the mucosal barrier. The presence of flavone and sterols may also be responsible.
- Antioxidant activity: The antioxidant capacity of skin, pulp, and seed of wax gourd extracts was measured by three different assays: scavenging activity, ferric reducing activity, and β-carotene bleaching assays. The seed extract of wax gourd showed the highest antioxidant capacity across all three assays and also exhibited the highest total phenolic content, as compared to skin and pulp extracts.
- Anti-diabetic constituents from pericarp: The inhibitory activity of extracts and fractions against advanced glycation end-product (AGE) formation and α-glucosidase activity has been evaluated, as these assays are relevant for the treatment of type 2 diabetes and its complications.
4. Scientific Evidence by Area of Use
Important note on evidence quality: As reviewed across the published literature, the main bioactive compounds contained in Benincasa hispida have cytotoxic, anti-inflammatory, and anticancer properties. However, further safety and efficacy investigations are needed to confirm these beneficial therapeutic effects, and future human clinical studies are required. The overwhelming majority of mechanistic and efficacy evidence originates from animal models and in vitro studies. Human clinical trial data is very limited.
4.1 Metabolic Health — Type 2 Diabetes and Blood Glucose
Human/Clinical Evidence: One of the only identified placebo-controlled human studies was conducted in Malaysia. There is emerging evidence of benefits of Benincasa hispida in improving metabolic profiles in people with diabetes. This study analyzed the effect of B. hispida aqueous extract on metabolic control of patients with type 2 diabetes. A powdered drink formulated with 2.5 g of B. hispida extract was prepared as a test food. An intervention study was conducted with 50 participants randomly assigned to an intervention or a control group, with anthropometric, biochemical, and clinical variables assessed at baseline and week 12. The intervention group presented a significant reduction in diastolic blood pressure (Δ −7.0 mmHg, 95% CI: −11.4, −2.5). Mean fasting plasma glucose showed a greater reduction in the intervention group compared to the control group. This study is preliminary due to its small sample size (n=50) and single-site design.
Preclinical Evidence: Benincasa hispida at doses of 250 and 500 mg/kg in mice induced a dose-dependent decrease in glucose, triglyceride, and insulin levels in plasma, and also increased glucose uptake from hemidiaphragm. Blood serum of mice on a high-fat diet showed elevated glucose, triglycerides, total protein, urea, and cholesterol. Treatment with Benincasa hispida extract significantly restored these biochemical parameters to near-normal levels.
A dietary supplementation study, though not a pure B. hispida trial, noted that supplementation of ash gourd and curry leaves to hyperlipidemic diabetic patients for three months had a significant hypoglycemic and hypolipidemic effect, reducing blood glucose levels (both fasting and post-prandial). This study has significant limitations, including the multi-ingredient intervention and small scale.
Strength of evidence: Preliminary. One small human trial with promising but not definitive findings; broader support comes from animal and in vitro studies only.
4.2 Gastroprotection and Antiulcer Activity
Preclinical Evidence: The antiulcer activity of Benincasa hispida fruit was evaluated in rats against ethanol-induced gastric mucosal damage, pylorus-ligated gastric ulcers, and cold restraint-stress-induced gastric ulcer models. Petroleum ether and methanol extracts were administered orally at a dose of 300 mg/kg, and omeprazole at 20 mg/kg served as the reference standard. Both extracts produced significant reduction in ulcer index (P < 0.05) in all models, and the results were comparable to those of the omeprazole-treated group. Significant reduction in vascular permeability (P < 0.05) was also observed.
The free radical scavenging and antiulcer potential of the methanol extract of Benincasa hispida seeds was also evaluated. The methanolic extract showed concentration-dependent DPPH radical scavenging activity and inhibited gastric ulceration by decreasing gastric volume and free and total acidity. The high dose (300 mg/kg) showed significant reduction in these parameters comparable to the standard drug ranitidine (p < 0.05). The extract caused 52.7%, 67.4%, and 61.2% inhibition of ulcers in pyloric ligation, water immersion stress, and indomethacin-induced ulcer models, respectively.
Strength of evidence: Moderate preclinical evidence from multiple rodent models; no human clinical trials identified.
4.3 Central Nervous System — Antidepressant, Anxiolytic, and Nootropic Effects
Preclinical Evidence: The methanolic extract of B. hispida showed significant antidepressant-like activity in mice, probably by inhibiting MAO-A and through interaction with dopaminergic, α1-adrenergic, serotoninergic, and GABAergic systems. The extract may be further studied to identify the particular active component(s) responsible.
One study evaluated the impact of dried fruit extract of Benincasa hispida on brain behavior in laboratory animals, emphasizing its potential as an alternative treatment for neurodegenerative disorders. The research highlighted the anxiolytic effects of Benincasa hispida, showing significant results in enhancing open arm entries and time spent in open arms during elevated plus maze testing. Benincasa hispida exhibited significant anxiolytic and nootropic activities at doses of 400 mg/kg. The study assessed the effects of petroleum ether, methanolic, and aqueous extracts on mice behavior.
Chronic treatment with the aqueous extract of Benincasa hispida pulp at 400 mg/kg body weight appeared beneficial in the management of a colchicine-induced rat model of Alzheimer's disease. It also increased antioxidants in different brain areas and increased the number of correct choices in daily trials while decreasing latency.
The juice of Benincasa hispida showed significant activity against symptoms of morphine withdrawal. The results showed that Benincasa hispida was active in preventing the development of morphine addiction in animal models.
Strength of evidence: Preliminary; entirely preclinical (rodent models and in vitro). No human studies identified for any CNS indication.
4.4 Anti-inflammatory and Analgesic Effects
Preclinical Evidence: The methanolic extract of the fruit is reported to possess antiulcer, anti-inflammatory, antihistaminic, and antidepressant activities. Two triterpenes — alnusenol and multiflorenol — extracted from the methanolic extract of B. hispida fruit exhibited mast cell-stabilizing effects and found to have potential inhibitory effects on histamine release, protecting against histamine-induced bronchospasm even at a very low dose of 50 mg/kg orally. However, even at a higher dose level of 400 mg/kg, the extract did not significantly protect against acetylcholine-induced bronchospasm.
Strength of evidence: Preliminary; preclinical only.
4.5 Diuretic Activity
Preclinical Evidence: The diuretic activity of the Benincasa hispida fruit rind extract (outer thick pericarp) at doses of 25–200 mg/kg was evaluated in adult male guinea pigs. The extract produced a significant increase (p < 0.001) in urinary output. This traditional indication is thus supported by animal data, though human confirmation is lacking.
Strength of evidence: Preliminary; animal study only.
4.6 Anticancer and Anti-Angiogenic Activity
In vitro and Cell-Line Evidence: One study aimed to investigate the possible therapeutic benefits of Benincasa hispida extract as an adjunctive treatment for breast cancer. While previous studies had highlighted anticancer effects of various components, there remained a paucity of research on seeds in the context of cancer. The cytotoxic impact was assessed via in vitro analysis employing the MTT assay. Apoptosis levels were assessed via the Annexin V assay, and cell cycle analysis and ROS quantification were also conducted. The findings demonstrated notable anti-proliferative properties, highlighting the extract's ability to induce apoptotic cell death and to cause cell cycle arrest at the S-phase.
Strength of evidence: Very preliminary; in vitro only. No animal or human data for oncological endpoints.
4.7 Anti-obesity and Hypolipidemic Activity
Preclinical Evidence: One study evaluated the therapeutic potential of Benincasa hispida in obesity-associated inflammatory bowel disease. Approximately 18 compounds sourced from Benincasa hispida were analyzed, among which 11 presented favorable drug-likeness scores and adherence to Lipinski's Rule of Five. Methodologies included compound-gene set pathway enrichment analysis, network pharmacology, docking studies, and molecular dynamics simulations. This was a computational study without clinical validation.
Strength of evidence: Very preliminary; computational and preclinical only. No human clinical trials identified specifically for obesity.
4.8 Antioxidant Activity
The aqueous extract of B. hispida has been shown to reduce reactive oxygen species (ROS) in human umbilical cell models. Antioxidant effects of various parts of B. hispida have been observed by several authors across multiple test models. Antioxidant effects are consistently reported across in vitro models using DPPH, ABTS, and ferric reducing power assays, particularly for seed extracts.
Strength of evidence: Consistent in vitro evidence; limited translational value without human bioavailability and clinical outcome data.
5. Body Systems and Health Areas Associated with Wax Gourd
Various parts of Benincasa hispida — including fruits, fruit peels, leaves, stems, and roots — exhibit antioxidant, anti-inflammatory, cytotoxic, anticancer, anti-obesity, hypolipidemic, neuroprotective, anticonvulsant, anxiolytic, antidiabetic, anti-aging, bronchodilation, antihypertensive, gastroprotective, analgesic, anti-asthmatic, diuretic, and antimicrobial effects. The seeds and seed oil exhibit anti-angiogenic, antioxidant, anti-urolithiatic, nephroprotective, antipyretic, analgesic, gastroprotective, diuretic, anthelmintic, and anticonvulsant effects.
The following body systems are represented in the published literature:
- Gastrointestinal system: Gastroprotection, antiulcer activity, relief of hyperacidity, laxative properties.
- Central nervous system: Anxiolytic, antidepressant, nootropic/cognitive, anticonvulsant, and potential utility in Alzheimer's disease models.
- Metabolic/endocrine system: Antidiabetic, hypoglycemic, hypolipidemic, anti-obesity.
- Renal and urinary system: Diuretic, nephroprotective, anti-urolithiatic (kidney stone-preventive).
- Respiratory system: Anti-asthmatic, histamine-release inhibition.
- Cardiovascular system: Antihypertensive (nitric oxide-dependent hypotensive effects have been reported for wax gourd juice in preclinical literature).
- Immune and inflammatory system: Anti-inflammatory, immunostimulant.
- Oncology (preclinical): Anti-proliferative and anti-angiogenic in cell lines.
6. Dosage Forms and Dosages Reported in Studies
Dosages reported in the scientific literature vary widely by preparation, plant part, and experimental model. The following are taken directly from sourced studies:
- Fruit extract (antiulcer, rat study): Petroleum ether and methanol extracts administered orally at 300 mg/kg body weight.
- Seed methanol extract (antiulcer, rat study): High dose of 300 mg/kg body weight produced significant reduction in ulcer parameters comparable to ranitidine.
- Fruit extract (antidiabetic, mouse study): Doses of 250 and 500 mg/kg induced dose-dependent decreases in glucose, triglyceride, and insulin levels in plasma.
- Aqueous extract of pulp (Alzheimer's disease model, rat study): 400 mg/kg body weight, administered chronically.
- Dried fruit extract (anxiolytic/nootropic, mouse study): Significant anxiolytic and nootropic activities at doses of 400 mg/kg.
- Human trial (type 2 diabetes, Malaysia): A powdered drink formulated with 2.5 g of B. hispida aqueous extract, consumed over 12 weeks.
- Fruit rind extract (diuretic, guinea pig study): Doses of 25–200 mg/kg of the outer pericarp extract.
No standardized or pharmacopeially recognized human therapeutic dosage for Benincasa hispida as a supplement has been established in the reviewed literature. The dosages used in preclinical studies are not directly translatable to human dosing.
7. Safety Considerations
Toxicological Assessment
The results of acute and sub-chronic toxicity studies suggest that the standardized hydro-alcoholic (70% ethanol) extract of the fruit pulp of Benincasa hispida is relatively safe when administered orally to female and male rats. The LD50 value of Benincasa hispida extract was greater than 2000 mg/kg. The extract did not show changes in haematological, biochemical, or histological parameters in the sub-chronic study.
All extracts tested (petroleum ether, methanolic, and aqueous) were safe at doses up to 2 g/kg in acute toxicity tests in mice.
Known or Theorized Interactions and Cautions
It has been used traditionally for the management of various pathological conditions, including obesity, ulcers, epilepsy, bleeding piles, hyperacidity, haemoptysis, dysuria, and urinary calculi. Its diuretic activity, demonstrated preclinically, raises theoretical concern regarding interactions with prescription diuretics or antihypertensive agents. The antidiabetic preclinical effects suggest the potential for additive effects with blood glucose-lowering medications, though this has not been evaluated in humans.
The methanolic extract's interaction with dopaminergic, α1-adrenergic, serotoninergic, and GABAergic systems suggests the theoretical possibility of pharmacodynamic interactions with neurologically active medications, though this has only been demonstrated in mice.
Limitations of the Safety Database
Formal safety evaluation in humans remains very limited. Preclinical studies have demonstrated nephroprotective potential in rodent models of acute and sub-chronic toxicity. However, the potential pharmacological targets and mechanisms underlying the ethnopharmacological aspects remain to be fully elucidated. No large-scale, long-duration human safety trials have been published in the reviewed literature.
References
Go back